FAS Wealth Partners Inc. Has $2 Million Stock Holdings in CME Group Inc. (NASDAQ:CME)

FAS Wealth Partners Inc. increased its position in shares of CME Group Inc. (NASDAQ:CMEFree Report) by 12.9% during the fourth quarter, Holdings Channel reports. The institutional investor owned 9,477 shares of the financial services provider’s stock after purchasing an additional 1,082 shares during the quarter. FAS Wealth Partners Inc.’s holdings in CME Group were worth $1,996,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors have also added to or reduced their stakes in CME. Naples Global Advisors LLC lifted its stake in CME Group by 5.6% during the fourth quarter. Naples Global Advisors LLC now owns 2,072 shares of the financial services provider’s stock worth $436,000 after purchasing an additional 110 shares during the period. FNY Investment Advisers LLC bought a new position in shares of CME Group in the fourth quarter valued at approximately $1,074,000. Deutsche Bank AG raised its stake in shares of CME Group by 4.3% in the third quarter. Deutsche Bank AG now owns 1,118,104 shares of the financial services provider’s stock valued at $223,867,000 after acquiring an additional 46,021 shares during the last quarter. Foundry Financial Group Inc. bought a new position in shares of CME Group in the fourth quarter valued at approximately $1,986,000. Finally, DNB Asset Management AS raised its stake in shares of CME Group by 34.6% in the fourth quarter. DNB Asset Management AS now owns 98,317 shares of the financial services provider’s stock valued at $20,706,000 after acquiring an additional 25,257 shares during the last quarter. 87.75% of the stock is owned by institutional investors and hedge funds.

CME Group Stock Performance

Shares of CME Group stock opened at $214.80 on Wednesday. The company has a debt-to-equity ratio of 0.13, a current ratio of 1.02 and a quick ratio of 1.02. The firm has a market cap of $77.33 billion, a P/E ratio of 24.22, a P/E/G ratio of 3.40 and a beta of 0.49. The firm has a 50 day simple moving average of $212.84 and a 200 day simple moving average of $211.04. CME Group Inc. has a fifty-two week low of $175.73 and a fifty-two week high of $223.80.

CME Group (NASDAQ:CMEGet Free Report) last issued its quarterly earnings results on Wednesday, February 14th. The financial services provider reported $2.37 earnings per share for the quarter, beating analysts’ consensus estimates of $2.27 by $0.10. CME Group had a net margin of 57.83% and a return on equity of 12.32%. The business had revenue of $1.44 billion during the quarter, compared to analyst estimates of $1.43 billion. During the same quarter last year, the business posted $1.92 earnings per share. CME Group’s revenue for the quarter was up 19.2% compared to the same quarter last year. Sell-side analysts predict that CME Group Inc. will post 9.63 earnings per share for the current fiscal year.

CME Group Increases Dividend

The firm also recently announced a quarterly dividend, which was paid on Tuesday, March 26th. Shareholders of record on Friday, March 8th were issued a dividend of $1.15 per share. This represents a $4.60 dividend on an annualized basis and a yield of 2.14%. The ex-dividend date of this dividend was Thursday, March 7th. This is a positive change from CME Group’s previous quarterly dividend of $1.10. CME Group’s payout ratio is currently 51.86%.

Analyst Ratings Changes

A number of research analysts have recently issued reports on CME shares. Barclays lifted their target price on shares of CME Group from $222.00 to $225.00 and gave the company an “equal weight” rating in a research note on Thursday, February 15th. The Goldman Sachs Group cut shares of CME Group from a “neutral” rating to a “sell” rating and set a $195.00 target price for the company. in a research note on Wednesday, January 3rd. Argus lifted their target price on shares of CME Group from $225.00 to $245.00 and gave the company a “buy” rating in a research note on Wednesday, March 6th. Finally, Rosenblatt Securities reissued a “sell” rating and issued a $180.00 price target on shares of CME Group in a report on Thursday, January 4th. Two research analysts have rated the stock with a sell rating, five have issued a hold rating and four have assigned a buy rating to the company. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average target price of $217.30.

Read Our Latest Research Report on CME

CME Group Profile

(Free Report)

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.

Recommended Stories

Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CMEFree Report).

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.